LinuxToaster BioPharma automates quality checks on regulatory submissions — validating thousands of references, cross-links, and consistency checks that no human team can cover at scale. The same work the FDA is now doing with AI on their side.
A single regulatory submission can contain thousands of references, cross-links, and internal consistency requirements. The FDA is no longer using humans to validate them. Biopharma shouldn't either.
Regulatory submissions contain thousands of cross-references, hyperlinks, and citations. Every one must resolve correctly. A single broken link found during review can trigger a deficiency letter.
A documentation deficiency found during an FDA inspection can delay drug approval by 6–12 months — at $1–5M per day in lost revenue for a commercial-stage product.
The FDA is using AI to validate references, check links, and flag inconsistencies in submissions. If their AI catches something your team missed, you're already behind.
Getting the combination of probabilistic AI and deterministic software right is what delivers results. Most AI tools treat the model as the entire system — prompt in, answer out, hope for the best. LinuxToaster BioPharma uses software harnesses to constrain and validate AI at every step. The AI does what it's good at — reading, extracting, synthesizing. Code does the rest: enforcing rules, validating references, checking structure, ensuring consistency. Every finding in a report is traceable to a verifiable check, not a guess.
Regulatory rules, reference validation, and cross-document checks are enforced by code — not left to probabilistic inference. AI handles extraction and synthesis; software handles correctness.
When the system flags a broken reference or a version conflict, that finding comes with a citation chain — which document, which field, which rule it violated. Your team reviews evidence, not AI opinions.
We hardened systems to CIS benchmarks before we built document analysis. That experience — knowing where security, auditability, and correctness requirements intersect — is baked into the architecture. We don't bolt compliance on after the fact.
These are the numbers your quality and compliance teams already live with.
From trial master files to final regulatory submissions, the same engine applies: AI reads and extracts, deterministic code validates and verifies, humans review and decide.
Automated consistency checking across your Trial Master File. Identifies gaps, missing signatures, version conflicts, and reference model deviations — then generates a prioritized findings report for human review.
Validate the thousands of references, hyperlinks, and cross-citations in your submission before the FDA's AI does. Software checks every link resolves, every reference exists, every cross-document claim is consistent.
Standardize heterogeneous data deliverables from multiple CROs into a consistent internal format.
Cross-check tables, figures, and in-text references within CSRs for internal consistency before submission.
The same engine — AI reads, code verifies — extends to defense, legal, and financial services with industry-specific rulesets.
We know the appliance won't get installed until IT and InfoSec sign off. Here's what they'll find.
Documents are stored and processed on an encrypted local appliance. Sensitive data never traverses a network. De-identified content can optionally route to cloud models for deeper analysis — you control what stays local and what doesn't.
Every document processed, every model invocation, every output generated is logged with timestamps, model versions, and input hashes.
We own the validation burden so you don't have to. Our SDLC is fully traceable, our toolchain is controlled to GxP standards, and we deliver complete validation packages — no hidden cost for your quality team.
We're pursuing industry-standard accreditations to streamline your procurement and security review process.
If your team is spending thousands of hours on manual document QC — or losing sleep over what an FDA inspection might find — we should talk.
30 minutes with a founder. No pitch deck — we'll ask about your workflow and tell you honestly if we're a fit.